PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles

Milan S. Geybels, Min Fang, Jonathan L. Wright, Xiaoyu Qu, Marina Bibikova, Brandy Klotzle, Jian-Bing Fan, Ziding Feng, Elaine A. Ostrander, Peter S. Nelson, Janet L. Stanford

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)84338-84348
Number of pages11
JournalOncotarget
Volume8
Issue number48
DOIs
Publication statusPublished - 13 Oct 2017

Keywords

  • phosphatase with tensin homology
  • epigenetics
  • prostate tumor methylation
  • recurrence and prognosis
  • RADICAL PROSTATECTOMY
  • SUPPRESSOR PTEN
  • ERG EXPRESSION
  • PATHWAY
  • RISK
  • PROGRESSION
  • DELETION
  • PI3K
  • IDENTIFICATION
  • PROGNOSIS

Cite this

Geybels, M. S., Fang, M., Wright, J. L., Qu, X., Bibikova, M., Klotzle, B., Fan, J-B., Feng, Z., Ostrander, E. A., Nelson, P. S., & Stanford, J. L. (2017). PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. Oncotarget, 8(48), 84338-84348. https://doi.org/10.18632/oncotarget.20940